Evidence map›Paper›PMID 37596541›Full record

Trial reportBMC neurology2023

COVCOG: Immediate and long-term cognitive improvement after cognitive versus emotion management psychoeducation programs - a randomized trial in covid patients with neuropsychological difficulties.

Sylvie Willems, Vincent Didone, Carmen Cabello Fernandez, Gael Delrue, Hichem Slama, Patrick Fery, Julien Goin, Clara Della Libera, COVCOG Group, Fabienne Collette

Erratum issued Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in BMC neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT05167266 (Immediate and Long Term Cognitive Improvement After Cognitive Versus Emotion Management Psychoeducation Programs), which is not on this map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05167266 nacompletednot on this map

Immediate and Long Term Cognitive Improvement After Cognitive Versus Emotion Management Psychoeducation Programs: a Randomised Trial in Covid Patients With Neuropsychological Difficulties

TypeinterventionalSponsorUniversity of LiegeRan2022 to 2024Enrolled130ConditionsCOVID-19, Cognitive DysfunctionArmsPsychoeducation
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Profiles of Individuals With Long COVID Reporting Persistent Cognitive Complaints.Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2025
    Trial
  3. Trial
  4. Article
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Sylvie WillemsPsychology and Neuroscience of Cognition Unit, Université de Liège, Place Des Orateurs, 1, B33 4000, Liège, Belgium. Sylvie.willems@uliege.be.
Vincent DidonePsychology and Neuroscience of Cognition Unit, Université de Liège, Place Des Orateurs, 1, B33 4000, Liège, Belgium.
Carmen Cabello FernandezPsychology and Neuroscience of Cognition Unit, Université de Liège, Place Des Orateurs, 1, B33 4000, Liège, Belgium.
Gael DelrueClinical Neuropsychological Unit, Liège University Hospital, CHU de Liège, Liège, Belgium.
Hichem SlamaClinical Neuropsychological Unit, Brussel University Hospital, Erasme, Brussels, Belgium.
Patrick FeryClinical Neuropsychological Unit, Brussel University Hospital, Erasme, Brussels, Belgium.
Julien GoinUniversity Psychology and Speech Therapy Clinic, CPLU, Université de Liège, Liège, Belgium.
Clara Della LiberaUniversity Psychology and Speech Therapy Clinic, CPLU, Université de Liège, Liège, Belgium.
COVCOG Group
Fabienne CollettePsychology and Neuroscience of Cognition Unit, Université de Liège, Place Des Orateurs, 1, B33 4000, Liège, Belgium.
University of Liège · BEErasmus Hospital · BECentre Hospitalier Universitaire de Liège · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCognitive difficulties are a frequent complaint in long COVID and persist for more than a year post- infection. There is a lack of evidence-based data on effective intervention strategies. Non-pharmacological intervention programs that are used with other neurological populations have not yet been the subject of controlled trials. COVCOG is a multicentric, randomized trial comparing cognitive intervention and a cognitive-behavioural counselling. METHODS/

designPatients with long covid are selected and recruited at least three months post-infection. Patients are randomised in a 1:1 ratio into the cognitive (neuropsychological psychoeducation) and affective (emotion management with cognitive-behavioural counselling) intervention arms. The inclusion of 130 patients is planned. The cognitive intervention includes psycho-educational modules on fatigue and sleep, attention and working memory, executive functions and long-term memory. The affective intervention includes modules on emotion recognition and communication, uncertainty management and behavioral activation. The main objective is to reduce cognitive complaints 2 months after the intervention. A Follow-up is also planned at 8 months. DISCUSSION: Given the long-term effects of Covid on cognition and the negative effects of cognitive impairment on quality of life and social participation, it is important to determine whether low-dose, non-pharmacological interventions can be effective. The trial will determine which of the usual types of intervention is the most effective.

trial registrationClinicaltrials.gov Number: NCT05167266 (21/12/ 2021).

Indexed as

COVID-19CognitionEmotionsHumansPost-Acute COVID-19 SyndromeQuality of LifeCognitive behavior counselingCognitive impairmentCognitive rehabilitationCounselingLong COVIDPost-acute COVIDPsychoeducation

Identifiers

PMID37596541
PMCPMC10436391
OpenAlexW4385984578

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.